| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-05 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-05 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-05 |
| mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-05 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-05 |
| mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
4e-05 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-05 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-05 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
7e-05 |